1993
Cellular replacement of dopamine deficit in Parkinson's disease using human fetal mesencephalic tissue: preliminary results in four patients.
Redmond D, Robbins R, Naftolin F, Marek K, Vollmer T, Leranth C, Roth R, Price L, Gjedde A, Bunney B. Cellular replacement of dopamine deficit in Parkinson's disease using human fetal mesencephalic tissue: preliminary results in four patients. Proceedings Of The Association For Research In Nervous And Mental Disease 1993, 71: 325-59. PMID: 8417471.Peer-Reviewed Original Research
1991
Mechanisms of action of atypical antipsychotic drugs Implications for novel therapeutic strategies for schizophrenia
Deutch A, Moghaddam B, Innis R, Krystal J, Aghajanian G, Bunney B, Charney D. Mechanisms of action of atypical antipsychotic drugs Implications for novel therapeutic strategies for schizophrenia. Schizophrenia Research 1991, 4: 121-156. PMID: 1674882, DOI: 10.1016/0920-9964(91)90030-u.Peer-Reviewed Original ResearchConceptsAtypical antipsychotic drugsAntipsychotic drugsDopamine D2 receptor antagonismD2 receptor antagonismAtypical profileNovel therapeutic strategiesDopamine D2 receptorsMechanism of actionAtypical agentsReceptor antagonismClinical dataD2 receptorsTherapeutic strategiesDrug profileDrugs implicationsMode of actionDrugsAntagonismClozapineRacloprideSerotoninSubtypesSchizophrenia
1990
A small volume chamber for electrical recording from submerged brain slices and a pulse-free medium supply system using a peristalic pump
Shi W, Bunney B. A small volume chamber for electrical recording from submerged brain slices and a pulse-free medium supply system using a peristalic pump. Journal Of Neuroscience Methods 1990, 35: 235-240. PMID: 2084393, DOI: 10.1016/0165-0270(90)90129-4.Peer-Reviewed Original Research
1987
Central dopamine-peptide interactions: Electrophysiological studies
Bunney B. Central dopamine-peptide interactions: Electrophysiological studies. Neuropharmacology 1987, 26: 1003-1009. PMID: 3309707, DOI: 10.1016/0028-3908(87)90079-7.Peer-Reviewed Original ResearchConceptsDA systemSelective non-peptide antagonistMidbrain DA systemsCentral DA systemsNon-peptide antagonistsPotential therapeutic valuePotential clinical interestDA neuronsDA cellsElectrophysiological studiesMental disordersTherapeutic valueEffects of peptidesSpecific receptorsAnatomical evidenceClinical interestEndogenous substancesPeptide systemBrainPhysiological activityVariety of peptidesBehavioral studiesPhysiological relevancePeptidesActive peptidesElectrophysiological studies on the specificity of the cholecystokinin antagonist proglumide
Chiodo L, Freeman A, Bunney B. Electrophysiological studies on the specificity of the cholecystokinin antagonist proglumide. Brain Research 1987, 410: 205-211. PMID: 3036308, DOI: 10.1016/0006-8993(87)90317-9.Peer-Reviewed Original ResearchConceptsExcitatory effectsInhibitory effectA9 DA neuronsCCK receptor blockadeSelective CCK antagonistsMidbrain dopamine cellsPrefrontal cortical neuronsInhibitory potencyDA neuronsReceptor blockadeChronic treatmentSensorimotor cortexC-terminal octapeptideCCK antagonistsDA cellsSubstance PAPO effectsCortical neuronsDopamine cellsIntravenous administrationSelective antagonistRat CNSProglumideElectrophysiological studiesCholecystokinin
1985
Further Studies on the Specificity of Proglumide as a Selective Cholecystokinin Antagonist in the Central Nervous Systema
BUNNEY B, CHIODO L, FREEMAN A. Further Studies on the Specificity of Proglumide as a Selective Cholecystokinin Antagonist in the Central Nervous Systema. Annals Of The New York Academy Of Sciences 1985, 448: 345-351. PMID: 2862828, DOI: 10.1111/j.1749-6632.1985.tb29929.x.Peer-Reviewed Original Research